These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 34562656)
1. pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis. Xu H; Luo R; Dong L; Pu X; Chen Q; Ye N; Qi S; Han X; Nie W; Fu C; Hu Y; Zhang J; Gao F Nanomedicine; 2022 Jan; 39():102461. PubMed ID: 34562656 [TBL] [Abstract][Full Text] [Related]
2. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery. Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992 [TBL] [Abstract][Full Text] [Related]
3. "Dual sensitive supramolecular curcumin nanoparticles" in "advanced yeast particles" mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment. Han X; Luo R; Qi S; Wang Y; Dai L; Nie W; Lin M; He H; Ye N; Fu C; You Y; Fu S; Gao F J Nanobiotechnology; 2023 Sep; 21(1):321. PubMed ID: 37679849 [TBL] [Abstract][Full Text] [Related]
4. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis. Gou S; Huang Y; Wan Y; Ma Y; Zhou X; Tong X; Huang J; Kang Y; Pan G; Dai F; Xiao B Biomaterials; 2019 Aug; 212():39-54. PubMed ID: 31103945 [TBL] [Abstract][Full Text] [Related]
5. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues. Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012 [TBL] [Abstract][Full Text] [Related]
6. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles. Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962 [TBL] [Abstract][Full Text] [Related]
7. Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment. Ye N; Zhao P; Ayue S; Qi S; Ye Y; He H; Dai L; Luo R; Chang D; Gao F Int J Biol Macromol; 2023 Mar; 232():123229. PubMed ID: 36642354 [TBL] [Abstract][Full Text] [Related]
8. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice. Li S; Jin M; Wu Y; Jung S; Li D; He N; Lee MS Drug Deliv; 2021 Dec; 28(1):1120-1131. PubMed ID: 34121560 [TBL] [Abstract][Full Text] [Related]
9. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics. Zhou X; Liu Y; Wang X; Li X; Xiao B Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A-loaded colon-targeted oral nanomicelles self-assembly by galactosylated carboxymethyl chitosan for efficient ulcerative colitis therapy. Xiong M; Li Y; He H; Hao S; Fang P; Xu M; Chen Y; Chen Y; Yu S; Hu H Eur J Pharm Biopharm; 2023 Aug; 189():152-164. PubMed ID: 37336365 [TBL] [Abstract][Full Text] [Related]
11. Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis. Sun L; Nie X; Lu W; Zhang Q; Fang W; Gao S; Chen S; Hu R AAPS PharmSciTech; 2022 Jun; 23(6):179. PubMed ID: 35761150 [TBL] [Abstract][Full Text] [Related]
12. Effect of adjusting pH and chondroitin sulfate on the formation of curcumin-zein nanoparticles: Synthesis, characterization and morphology. Feng S; Sun Y; Wang D; Sun P; Shao P Carbohydr Polym; 2020 Dec; 250():116970. PubMed ID: 33049899 [TBL] [Abstract][Full Text] [Related]
13. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release. Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273 [TBL] [Abstract][Full Text] [Related]
14. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation. Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161 [TBL] [Abstract][Full Text] [Related]
15. Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy. Chen Q; Gou S; Ma P; Song H; Zhou X; Huang Y; Kwon Han M; Wan Y; Kang Y; Xiao B Int J Pharm; 2019 Feb; 557():135-144. PubMed ID: 30594685 [TBL] [Abstract][Full Text] [Related]
16. pH/ROS Dual-Sensitive Natural Polysaccharide Nanoparticles Enhance "One Stone Four Birds" Effect of Rhein on Ulcerative Colitis. Qi S; Luo R; Han X; Nie W; Ye N; Fu C; Gao F ACS Appl Mater Interfaces; 2022 Nov; 14(45):50692-50709. PubMed ID: 36326017 [TBL] [Abstract][Full Text] [Related]
17. Dual-Sensitive Carbohydrate-Based Nanosystem for Targeted Drug Delivery to Potentiate the Therapeutic Efficacy of Ulcerative Colitis. Wang Y; Song X; Cui R; Luo X; Dong J; Wang H; Song C; Zhou Y; Cui S Int J Nanomedicine; 2024; 19():8555-8572. PubMed ID: 39185345 [TBL] [Abstract][Full Text] [Related]
18. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy. Wang X; Gu H; Zhang H; Xian J; Li J; Fu C; Zhang C; Zhang J ACS Appl Mater Interfaces; 2021 Jul; 13(29):33948-33961. PubMed ID: 34261306 [TBL] [Abstract][Full Text] [Related]
19. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy. Xiao B; Si X; Zhang M; Merlin D Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840 [TBL] [Abstract][Full Text] [Related]
20. Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis. Luo R; Lin M; Zhang C; Shi J; Zhang S; Chen Q; Hu Y; Zhang M; Zhang J; Gao F Food Chem; 2020 Nov; 330():127241. PubMed ID: 32540526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]